Free Trial

Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume

$7.57 -0.01 (-0.13%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$7.57 0.00 (0.00%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Global X Genomics & Biotechnology ETF Short Interest Data

Global X Genomics & Biotechnology ETF (GNOM) has a short interest of 24,100 shares, representing 0.40% of the float (the number of shares available for trading by the public). This marks a 46.95% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 63,974 shares to cover all short positions.

Current Short Interest
24,100 shares
Previous Short Interest
16,400 shares
Change Vs. Previous Month
+46.95%
Dollar Volume Sold Short
$191,595.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
6,060,000 shares
Short Percent of Float
0.40%
Today's Trading Volume
38,848 shares
Average Trading Volume
63,974 shares
Today's Volume Vs. Average
61%
Short Selling Global X Genomics & Biotechnology ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNOM Short Interest Over Time

GNOM Days to Cover Over Time

GNOM Percentage of Float Shorted Over Time

Global X Genomics & Biotechnology ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202524,100 shares $191,595.00 +47.0%0.4%0.3 $7.95
3/15/202516,400 shares $144,976.00 +30.2%0.3%0.2 $8.84
2/28/202512,600 shares $116,298.00 -40.0%0.2%0.2 $9.23
2/15/202521,000 shares $208,110.00 +65.4%0.3%0.3 $9.91
1/31/202512,700 shares $129,286.00 -13.0%N/A0.2 $10.18
1/15/202514,600 shares $141,036.00 -45.3%N/A0.2 $9.66
12/31/202426,700 shares $259,257.00 -20.1%N/A0.4 $9.71
12/15/202433,400 shares $343,018.00 +62.1%N/A0.6 $10.27
11/30/202420,600 shares $223,304.00 +174.7%N/A0.5 $10.84
11/15/20247,500 shares $72,375.00 -44.0%N/A0.2 $9.65
10/31/202413,400 shares $139,092.00 -21.2%N/A0.3 $10.38
10/15/202417,000 shares $186,660.00 -7.1%N/A0.4 $10.98
9/30/202418,300 shares $205,875.00 +21.2%N/A0.3 $11.25
9/15/202415,100 shares $171,243.06 -41.5%N/A0.3 $11.34
8/31/202425,800 shares $293,604.00 +6.6%N/A0.5 $11.38
8/15/202424,200 shares $273,387.40 +70.4%N/A0.4 $11.30
7/31/202414,200 shares $165,146.00 -10.1%N/A0.3 $11.63
7/15/202415,800 shares $179,646.00 +47.7%N/A0.3 $11.37
6/30/202410,700 shares $111,708.00 -32.7%N/A0.2 $10.44
6/15/202415,900 shares $166,314.00 +62.2%N/A0.3 $10.46
5/31/20249,800 shares $99,470.00 -31.9%N/A0.2 $10.15
5/15/202414,400 shares $157,248.00 -22.6%N/A0.2 $10.92
4/30/202418,600 shares $183,210.00 +69.1%N/A0.2 $9.85
4/15/202411,000 shares $112,750.00 No ChangeN/A0.1 $10.25
3/31/202411,000 shares $125,180.00 -77.9%N/A0.2 $11.38
3/15/202449,800 shares $571,206.00 -12.0%N/A0.7 $11.47
2/29/202456,600 shares $678,068.00 +133.9%N/A0.7 $11.98
2/15/202424,200 shares $276,848.00 +15.8%N/A0.4 $11.44
1/31/202420,900 shares $224,675.00 -20.8%N/A0.3 $10.75
1/15/202426,400 shares $299,376.00 +80.8%N/A0.1 $11.34
12/31/202314,600 shares $168,748.26 -9.9%N/A0.1 $11.56
12/15/202316,200 shares $183,546.00 -61.6%N/A0.1 $11.33
11/30/202342,200 shares $439,724.00 +47.6%N/A0.1 $10.42
11/15/202328,600 shares $287,716.00 -41.3%N/A0.1 $10.06
10/31/202348,700 shares $430,995.00 -28.5%N/A0.2 $8.85
10/15/202368,100 shares $661,932.00 -14.8%N/A0.3 $9.72
9/30/202379,900 shares $812,583.00 +415.5%N/A0.4 $10.17
9/15/202315,500 shares $168,795.00 -95.9%N/A0.1 $10.89
8/31/2023374,700 shares $4.21 million +4,963.5%N/A3.5 $11.23
8/15/20237,400 shares $82,880.00 -54.9%N/A0.1 $11.20
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
7/31/202316,400 shares $201,228.00 -64.7%N/A0.2 $12.27
7/15/202346,400 shares $568,864.00 -32.0%N/A0.8 $12.26
6/30/202368,200 shares $826,584.00 +44.8%N/A0.9 $12.12
6/15/202347,100 shares $607,590.00 -32.2%N/A0.6 $12.90
5/31/202369,500 shares $849,290.00 +100.9%N/A0.8 $12.22
5/15/202334,600 shares $452,222.00 +16.1%N/A0.4 $13.07
4/30/202329,800 shares $365,348.00 -60.5%N/A0.3 $12.26
4/15/202375,400 shares $944,762.00 -26.7%N/A0.8 $12.53
3/31/2023102,800 shares $1.27 million +139.6%N/A1.1 $12.32
3/15/202342,900 shares $526,383.00 +29.2%N/A0.5 $12.27
2/28/202333,200 shares $419,316.00 -61.4%N/A0.3 $12.63
2/15/202386,100 shares $1.14 million -13.3%N/A0.9 $13.29
1/31/202399,300 shares $1.35 million -23.7%N/A1 $13.58
1/15/2023130,200 shares $1.77 million +45.0%N/A1.3 $13.60
12/30/202289,800 shares $1.14 million -15.1%N/A0.8 $12.65
12/15/2022105,800 shares $1.39 million +63.8%N/A1 $13.09
11/30/202264,600 shares $872,100.00 +36.6%N/A0.7 $13.50
11/15/202247,300 shares $648,956.00 +48.3%N/A0.5 $13.72
10/31/202231,900 shares $419,485.00 -55.8%N/A0.3 $13.15
10/15/202272,100 shares $876,015.00 No ChangeN/A0.7 $12.15
9/30/2022110,000 shares $1.38 million -60.7%N/A1 $12.55
9/15/2022279,900 shares $3.97 million +232.0%N/A2.2 $14.19
8/31/202284,300 shares $1.17 million -43.7%N/A0.6 $13.83
8/15/2022149,800 shares $2.44 million +22.0%N/A1.1 $16.28
7/31/2022122,800 shares $1.75 million -25.3%N/A0.6 $14.24
7/15/2022164,400 shares $2.32 million -23.2%N/A0.8 $14.09
6/30/2022214,100 shares $2.62 million +237.2%N/A1.1 $12.22
6/15/202263,500 shares $706,120.00 +56.0%N/A0.4 $11.12
5/31/202240,700 shares $488,400.00 +2.8%N/A0.3 $12.00
5/15/202239,600 shares $467,676.00 -44.2%N/A0.2 $11.81
4/30/202271,000 shares $904,540.00 +30.3%N/A0.7 $12.74
4/15/202254,500 shares $790,250.00 +16.2%N/A0.5 $14.50
3/31/202246,900 shares $704,907.00 -1.3%N/A0.4 $15.03
3/15/202247,500 shares $644,100.00 -57.7%N/A0.3 $13.56
2/28/2022112,300 shares $1.74 million +18.7%N/A0.8 $15.46
2/15/202294,600 shares $1.54 million -0.9%N/A0.7 $16.31
1/31/202295,500 shares $1.54 million +41.3%N/A0.7 $16.14
1/15/202267,600 shares $1.16 million -18.5%N/A0.5 $17.22
12/31/202182,900 shares $1.65 million +18.8%N/A0.7 $19.85
12/15/202169,800 shares $1.42 million -30.8%N/A0.7 $20.38
11/30/2021100,800 shares $2.08 million +72.9%N/A1.1 $20.62
11/15/202158,300 shares $1.23 million -20.6%N/A0.6 $21.02
10/29/202173,400 shares $1.57 million +1.4%N/A0.9 $21.43
10/15/202172,400 shares $1.55 million +11.9%N/A0.9 $21.46
9/30/202164,700 shares $1.43 million -55.8%N/A0.8 $22.14
9/15/2021146,200 shares $3.43 million +56.5%N/A1.6 $23.46
8/31/202193,400 shares $2.25 million -31.2%N/A1 $24.12
8/13/2021135,700 shares $3.12 million +18.8%N/A1.5 $22.98
7/30/2021114,200 shares $2.62 million +13.0%N/A1.3 $22.93
7/15/2021101,100 shares $2.29 million -14.7%N/A1.1 $22.64
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
6/30/2021118,500 shares $2.95 million -4.1%N/A1.2 $24.89
6/15/2021123,500 shares $2.82 million +17.6%N/A1.1 $22.83
5/28/2021105,000 shares $2.26 million -48.8%N/A1 $21.50
5/14/2021205,000 shares $4.05 million +42.7%N/A1.6 $19.75
4/30/2021143,700 shares $3.29 million -30.7%N/A0.9 $22.87
4/15/2021207,300 shares $4.67 million +33.1%N/A1.3 $22.55
3/31/2021155,800 shares $3.34 million -4.3%N/A0.9 $21.44
3/15/2021162,800 shares $3.82 million +59.9%N/A0.9 $23.45
2/26/2021101,800 shares $2.42 million -75.1%N/A0.6 $23.77
2/12/2021408,900 shares $11.23 million +228.2%N/A2.8 $27.47
1/29/2021124,600 shares $3.12 million -15.4%N/A1.1 $25.07
1/15/2021147,300 shares $3.88 million No ChangeN/A1.6 $26.32

GNOM Short Interest - Frequently Asked Questions

What is Global X Genomics & Biotechnology ETF's current short interest?

Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 24,100 shares of GNOM short. 0.40% of Global X Genomics & Biotechnology ETF's shares are currently sold short. Learn More on Global X Genomics & Biotechnology ETF's current short interest.

What is a good short interest percentage for Global X Genomics & Biotechnology ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.40% of Global X Genomics & Biotechnology ETF's floating shares are currently sold short.

Is Global X Genomics & Biotechnology ETF's short interest increasing or decreasing?

Global X Genomics & Biotechnology ETF saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 24,100 shares, an increase of 47.0% from the previous total of 16,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Global X Genomics & Biotechnology ETF's short interest compare to its competitors?

0.40% of Global X Genomics & Biotechnology ETF's shares are currently sold short. Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: Tradr 2X Long Innovation ETF (5.89%), AOT Growth & Innovation ETF (0.06%), Fidelity Disruptive Medicine ETF (0.01%), Siren Nasdaq NexGen Economy ETF (0.30%), Procure Space ETF (3.69%), Spear Alpha ETF (2.54%), First Trust Dow Jones International Internet ETF (1.79%), Democratic Large Cap Core ETF (1.58%), Roundhill GLP-1 & Weight Loss ETF (0.08%), Global X Telemedicine & Digital Health ETF (0.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Global X Genomics & Biotechnology ETF stock?

Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Global X Genomics & Biotechnology ETF?

A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further.

How often is Global X Genomics & Biotechnology ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:GNOM) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners